Cargando…
Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab
Certain diabetic and hypertensive patients started on intravitreal vascular endothelial growth factor inhibition for diabetic retinopathy may experience worsening of hypertension and proteinuria. The etiology of this is the newly recognized absorption of intravitreally injected vascular endothelial...
Autores principales: | Hanna, Ramy M, Abdelnour, Lama, Hasnain, Huma, Selamet, Umut, Kurtz, Ira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026818/ https://www.ncbi.nlm.nih.gov/pubmed/32110410 http://dx.doi.org/10.1177/2050313X20907033 |
Ejemplares similares
-
Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension
por: Hanna, Ramy M, et al.
Publicado: (2018) -
Acute interstitial nephritis and drug-induced systemic lupus
erythematosus due to chlorthalidone and amiodarone: A case
report
por: Selamet, Umut, et al.
Publicado: (2020) -
Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
por: Shye, Michael, et al.
Publicado: (2020) -
Switching from Intravitreal Ranibizumab to Bevacizumab for
Age-Related Macular Degeneration
por: Yamada, Kisaburo, et al.
Publicado: (2011) -
Refractory scleroderma renal crisis precipitated after high-dose oral
corticosteroids and concurrent intravitreal injection of
bevacizumab
por: Hanna, Ramy M, et al.
Publicado: (2020)